UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage

Proceedings of the National Academy of Sciences - PNAS, 2011-10, Vol.108 (42), p.17372-17377

2011

Volltextzugriff (PDF)

The B cell response to citrullinated antigens in the development of rheumatoid arthritis

Nature reviews. Rheumatology, 2018-03, Vol.14 (3), p.157-169

2018

Volltextzugriff (PDF)

Genetics of rheumatoid arthritis: what have we learned?

Immunogenetics (New York), 2011-08, Vol.63 (8), p.459-466

2011

Volltextzugriff (PDF)

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

Rheumatology and therapy., 2021-03, Vol.8 (1), p.41-61

2021

Volltextzugriff (PDF)

Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis

Nature communications, 2024-04, Vol.15 (1), p.3114-3114, Article 3114

2024

Volltextzugriff (PDF)

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

Annals of the rheumatic diseases, 2010-08, Vol.69 (8), p.1554-1561

2010

Volltextzugriff (PDF)

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations

Arthritis research & therapy, 2023-03, Vol.25 (1), p.37-37, Article 37

2023

Volltextzugriff (PDF)

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Arthritis research & therapy, 2019-01, Vol.21 (1), p.28-28, Article 28

2019

Volltextzugriff (PDF)

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

Arthritis research & therapy, 2018-02, Vol.20 (1), p.33-33, Article 33

2018

Volltextzugriff (PDF)

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

Arthritis research & therapy, 2019-12, Vol.21 (1), p.268-268, Article 268

2019

Volltextzugriff (PDF)

Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach

Scientific reports, 2022-12, Vol.12 (1), p.21376-21376, Article 21376

2022

Volltextzugriff (PDF)

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1039-1046

2011

Volltextzugriff (PDF)

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

Arthritis research & therapy, 2021-09, Vol.23 (1), p.1-230, Article 230

2021

Volltextzugriff (PDF)

Anti-carbamylated protein antibodies in systemic sclerosis

Arthritis research & therapy, 2023-07, Vol.25 (1), p.123-123, Article 123

2023

Volltextzugriff (PDF)

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients

Scientific reports, 2019-03, Vol.9 (1), p.4521, Article 4521

2019

Volltextzugriff (PDF)

Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis

PloS one, 2021-03, Vol.16 (3), p.e0247847-e0247847

2021

Volltextzugriff (PDF)

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

Trials, 2022-11, Vol.23 (1), p.939-939, Article 939

2022

Volltextzugriff (PDF)

Ability of Interleukin‐33– and Immune Complex–Triggered Activation of Human Mast Cells to Down‐Regulate Monocyte‐Mediated Immune Responses

Arthritis & rheumatology (Hoboken, N.J.), 2015-09, Vol.67 (9), p.2343-2353

2015

Volltextzugriff (PDF)

Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2011-09, Vol.63 (9), p.2567-2574

2011

Volltextzugriff (PDF)

Platelets and autoimmunity

European journal of clinical investigation, 2013-07, Vol.43 (7), p.746-757

2013

Volltextzugriff (PDF)

A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis

PLoS medicine, 2007-09, Vol.4 (9), p.e278-e278

2007

Volltextzugriff (PDF)

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the article by Regueiro et al

Arthritis research & therapy, 2020-04, Vol.22 (1), p.85-85, Article 85

2020

Volltextzugriff (PDF)

Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis

PloS one, 2014-07, Vol.9 (7), p.e102163-e102163

2014

Volltextzugriff (PDF)

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Annals of the Rheumatic Diseases, 2016-06, Vol.75 (6), p.952-957

2016

Volltextzugriff (PDF)

The Course of Bone Marrow Edema in Early Undifferentiated Arthritis and Rheumatoid Arthritis: A Longitudinal Magnetic Resonance Imaging Study at Bone Level

Arthritis & rheumatology (Hoboken, N.J.), 2016-05, Vol.68 (5), p.1080-1088

2016

Volltextzugriff (PDF)

1 – 25 von 715

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(636)
Mit Volltextzugriff
(591)

Publikationsform

Artikel
(714)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(575)
Life Sciences & Biomedicine
(558)
Humans
(493)
Rheumatology
(416)
Female
(271)
Male
(262)
Rheumatoid Arthritis
(256)
Middle Aged
(220)
Adult
(170)
Biological And Medical Sciences
(159)
Medical Sciences
(146)
Aged
(143)
Diseases Of The Osteoarticular System
(115)
Arthritis, Rheumatoid - Immunology
(114)
Arthritis, Rheumatoid - Drug Therapy
(111)
Risk Factors
(99)
Arthritis, Rheumatoid - Genetics
(93)
Patients
(93)
Arthritis
(92)
Disease Progression
(87)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage

The B cell response to citrullinated antigens in the development of rheumatoid arthritis

Genetics of rheumatoid arthritis: what have we learned?

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

Anti-carbamylated protein antibodies in systemic sclerosis

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients

Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

Ability of Interleukin‐33– and Immune Complex–Triggered Activation of Human Mast Cells to Down‐Regulate Monocyte‐Mediated Immune Responses

Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis

Platelets and autoimmunity

A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the article by Regueiro et al

Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

The Course of Bone Marrow Edema in Early Undifferentiated Arthritis and Rheumatoid Arthritis: A Longitudinal Magnetic Resonance Imaging Study at Bone Level

Suchergebnisse filtern